Related Experiment Video

Updated: Jul 23, 2026

Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection
10:50

Design and Use of a Low Cost, Automated Morbidostat for Adaptive Evolution of Bacteria Under Antibiotic Drug Selection

Published on: September 27, 2016

The evolution of aminoglycoside therapy: a single daily dose

R L Deamer1, L K Dial

  • 1UCLA School of Medicine, Ventura County Medical Center, California, USA.

American Family Physician
|April 1, 1996
PubMed

Insights

Aminoglycoside antibiotics, crucial for gram-negative infections, can be safely administered once daily. This optimized dosing reduces toxicity and cost while maintaining efficacy.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Nephrology

Background:

  • Aminoglycosides are vital antibiotics for gram-negative infections.
  • Nephrotoxicity and ototoxicity are significant risks associated with traditional aminoglycoside dosing.
  • Optimizing aminoglycoside dosing is crucial for balancing efficacy and safety.

Purpose of the Study:

  • To evaluate the efficacy and safety of once-daily aminoglycoside dosing regimens.
  • To determine optimal once-daily dosage ranges for gentamicin, tobramycin, amikacin, and netilmicin.
  • To assess the potential for reduced toxicity and cost with modified dosing.

Main Methods:

  • Review of experimental data and clinical experience with aminoglycoside therapy.
  • Analysis of outcomes from standard (every 8-12 hours) versus once-daily dosing.
  • Determination of specific once-daily dosage recommendations (mg/kg) for key aminoglycosides.

Main Results:

  • Once-daily aminoglycoside dosing may improve clinical outcomes.
  • Modified dosing regimens show potential for reduced toxicity.
  • Cost-effectiveness of therapy may be enhanced with once-daily administration.
  • Recommended once-daily doses: gentamicin, tobramycin, netilmicin (4-7 mg/kg); amikacin (15-20 mg/kg).

Conclusions:

  • Once-daily aminoglycoside dosing is a viable strategy for managing gram-negative infections.
  • This dosing approach offers a favorable balance of efficacy, safety, and cost.
  • Specific once-daily dosage guidelines can optimize treatment with gentamicin, tobramycin, amikacin, and netilmicin.

More Related Videos

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat06:03

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat

Published on: September 20, 2016

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Concept Videos

Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...